Radiation Therapy of Patients with Squamous Cell Cancer of the Esophagus with an Electronic Device Implanted in the Heart. Cases Reports
I. A. Gladilina,
M. V. Chernykh,
E. A. Sukhova,
D. G. Ishchanov,
O. B. Abu-Khayda,
E. A. Dinaeva,
S. M. Ivanov https://doi.org/10.37174/2587-7593-2024-7-3-15-23
Abstract
Every year, about a million electronic devices implanted in the heart are installed worldwide. In the Russian Federation, there are no accurate statistics on pacemakers. Modern pacemakers (pacers) are characterized by their small size, high sensitivity and susceptibility to ionizing radiation (IR), which increases the risk of temporary or irreversible damage to the device. Throughout the world, the number of cancer patients with electronic devices implanted in the heart has increased over the past decade. Despite the development of modern methods of radiation therapy (RT), this method has a certain risk of complications for cancer patients with ECS.
We currently use the 2020 update of the JASTRO/JCS guidelines for RT in patients with cardiac implantable devices to guide management of patients with pacemakers. Similar recommendations have not yet been developed in the Russian Federation, as in many other countries, which makes this problem especially relevant.
This article demonstrates a multidisciplinary team approach to the management and treatment of patients with esophageal squamous cell carcinoma (ESCC) with an implantable pacemaker.
About the Authors
I. A. Gladilina
N.N. Blokhin National Medical Research Center of Oncology; N.I. Pirogov Russian National Research Medical University
Russian Federation
Competing Interests:
Russian Federation
Irina A. Gladilina
Author ID: 902224
4 Kashirskoe Shosse, Moscow, 115478
1 Ostrovityanov Str., Moscow 117997
Competing Interests:
The authors declare no conflict of interest
M. V. Chernykh
N.N. Blokhin National Medical Research Center of Oncology
Russian Federation
Competing Interests:
Russian Federation
Maria V. Chernykh
4 Kashirskoe Shosse, Moscow, 115478
Competing Interests:
The authors declare no conflict of interest
E. A. Sukhova
N.I. Pirogov Russian National Research Medical University
Russian Federation
Competing Interests:
Russian Federation
Ekaterina A. Sukhova
1 Ostrovityanov Str., Moscow 117997
Competing Interests:
The authors declare no conflict of interest
D. G. Ishchanov
N.N. Blokhin National Medical Research Center of Oncology
Russian Federation
Competing Interests:
Russian Federation
Damir G. Ishchanov
4 Kashirskoe Shosse, Moscow, 115478
Competing Interests:
The authors declare no conflict of interest
O. B. Abu-Khayda
N.N. Blokhin National Medical Research Center of Oncology
Russian Federation
Competing Interests:
Russian Federation
Omar B. Abu-Khayda
4 Kashirskoe Shosse, Moscow, 115478
Competing Interests:
The authors declare no conflict of interest
E. A. Dinaeva
N.N. Blokhin National Medical Research Center of Oncology
Russian Federation
Competing Interests:
Russian Federation
Elmira А. Dinaeva
4 Kashirskoe Shosse, Moscow, 115478
Competing Interests:
The authors declare no conflict of interest
S. M. Ivanov
N.N. Blokhin National Medical Research Center of Oncology
Russian Federation
Competing Interests:
Russian Federation
Stanislav M. Ivanov
Author ID: 635263
4 Kashirskoe Shosse, Moscow, 115478
Competing Interests:
The authors declare no conflict of interest
References
1. Aquilina O. A brief history of cardiac pacing. Images Paediatr Cardiol. 2006 Apr;8(2):17-81. PMID: 22368662; PMCID: PMC3232561.
2. Kulish AV, Ivanov AB. Vegaritm — the first Russian three-chamber pacemaker. High-Tech Technologies. 2014; 3:43 7.
3. Mulpuru SK, Madhavan M, McLeod CJ, et al. Cardiac Pace makers: Function, Troubleshooting, and Management: Part 1 of a 2-Part Series. J Am Coll Cardiol. 2017;69(2):189-210. https://doi.org/10.1016/j.jacc.2016.10.061. PMID: 28081829.
4. Qiao H, Jiang F, Ning P, et al. Safety Review of Radiothera py for Tumor Patients with Implantable Cardiac Pacemaker. Acta Cardiol Sin. 2023;39(6):807-816. https://doi.org/10.6515/ACS.202311_39(6).20230828A. PMID: 38022419; PMCID: PMC10646601.
5. Hurkmans CW, Knegjens JL, Oei BS, et al. Dutch Society of Ra diotherapy and Oncology (NVRO). Management of radiation oncology patients with a pacemaker or ICD: a new compre hensive practical guideline in The Netherlands. Dutch Soci ety of Radiotherapy and Oncology (NVRO). Radiat Oncol. 2012;7:198. https://doi.org/10.1186/1748-717X-7-198. PMID: 23176563; PMCID: PMC3528416.
6. 2021 ESC Guidelines on cardiac pacing and cardiac re synchronization therapy. Russian Journal of Cardiology. 2022;27(7):5159. (In Russ.) https://doi.org/10.15829/1560-4071-2022-5159
7. Ohno T, Soejima T, Sekiguchi Y, et al. JASTRO/JCS Guidelines for radiotherapy in patients with cardiac implantable elec tronic devices. J Radiat Res. 2020;62(1):172-84. https://doi.org/10.1093/jrr/rraa102. PMCID: PMC7779359.
8. Zecchin M, Severgnini M, Fiorentino A, et al. Management of patients with cardiac implantable electronic devices (CIED) undergoing radiotherapy: A consensus document from Associazione Italiana Aritmologia e Cardiostimolazione (AIAC), Associazione Italiana Radioterapia Oncologica (AIRO), Associazione Italiana Fisica Medica (AIFM). Int J Car diol. 2018;255:175-183. https://doi.org/10.1016/j.ijcard.2017.12.061. PMID: 29310933.
9. Gauter-Fleckenstein B, Israel CW, Dorenkamp M, et al. DEGRO/DGK. DEGRO/DGK guideline for radiotherapy in pa tients with cardiac implantable electronic devices. Strahlen ther Onkol. 2015;191(5):393-404. https://doi.org/10.1007/s00066-015-0817-3. PMID: 25739476.
10. Salerno F, Gomellini S, Caruso C, et al. Management of radia tion therapy patients with cardiac defibrillator or pacemaker. Radiol Med. 2016;121(6):515-20. https://doi.org/10.1007/s11547-015-0616-z. PMID: 26706454.
11. Zaremba T, Jakobsen AR, Søgaard M, et al. Radiotherapy in patients with pacemakers and implantable cardioverter de fibrillators: a literature review. Europace. 2016;18(4):479-91. https://doi.org/10.1093/europace/euv135. PMID: 26041870.
12. López-Honrubia V, Hidalgo-Olivares VM, Dobón-Roux M, et al. Radiotherapy is safe in patients with implantable cardiac devices. Analysis of a systematic interrogation follow-up. Clin Transl Oncol. 2020;22(12):2286-92. https://doi.org/10.1007/s12094-020-02374-y. PMID: 32419111.
13. Zaremba T, Jakobsen AR, Søgaard M, et al. Risk of device mal function in cancer patients with implantable cardiac device undergoing radiotherapy: a population-based cohort study. Pacing Clin Electrophysiol. 2015;38(3):343-56. https://doi.org/10.1111/pace.12572. PMID: 25601489.
Review
For citations:
Gladilina I.A., Chernykh M.V., Sukhova E.A., Ishchanov D.G., Abu-Khayda O.B., Dinaeva E.A., Ivanov S.M. Radiation Therapy of Patients with Squamous Cell Cancer of the Esophagus with an Electronic Device Implanted in the Heart. Cases Reports. Journal of oncology: diagnostic radiology and radiotherapy. 2024;7(3):15-23. (In Russ.) https://doi.org/10.37174/2587-7593-2024-7-3-15-23
Views:
238
Email this article 